Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Francisco Javier Ampudia-Blasco
Following the Results of the EMPA-REG OUTCOME Trial With Empagliflozin, Is It Possible to Speak of a Class Effect?
International Journal of General Medicine
Medicine
Real-Time Estimation of Plasma Insulin Concentration From Continuous Glucose Monitor Measurements
Computer Methods in Biomechanics and Biomedical Engineering
Medicine
Bioengineering
Computer Science Applications
Biomedical Engineering
Human-Computer Interaction
Related publications
Mortality Reduction in EMPA-REG OUTCOME Trial: Beyond the Antidiabetes Effect
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Pdb62 - Cost-Effectiveness Analysis of Empagliflozin in Japan Based on Results From the Subgroup Analysis of Asian Patients in the Empa-Reg Outcome Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Empa's New Clothes: The Untold Story of the Empa-Reg Outcome Trial
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
EMPA-REG OUTCOME: The Endocrinologist's Point of View
American Journal of Medicine
Medicine
EMPA-REG OUTCOME: The Nephrologist's Point of View
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
EMPA-REG OUTCOME: The Cardiologist's Point of View
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Consistent Cardiovascular (CV) Benefit of Empagliflozin Over the Spectrum of CV Risk Factor Control in EMPA-REG OUTCOME
Metabolism: Clinical and Experimental
Endocrinology
Metabolism
Diabetes
DECLARE-TIMI 58 Trial in the Context of EMPA-REG OUTCOME and CANVAS
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes
Is It Possible to Speak of Social Revolutions in Late Antiquity?
Mare Nostrum (São Paulo)
